Renin-angiotensin blockade attenuates cardiac myofibrillar remodelling in chronic diabetes

Molecular and Cellular Biochemistry

Volumn 261, Issue 1, 2004, Pages 271-278

  Machackova, Jarmila ^a   Liu, Xueliang ^a   Lukas, Anton ^a   Dhalla, Naranjan S ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Angiotensin receptor AT1 blocker; Angiotensin converting enzyme inhibitor; Myosin and myofibrillar ATPase; Myosin heavy chain isoform; Renin angiotensin system in diabetes

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CARDIAC MYOSIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ISOENZYME; LOSARTAN; MESSENGER RNA; MYOSIN ADENOSINE TRIPHOSPHATASE; MYOSIN HEAVY CHAIN; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE CELL; HEART PROTECTION; MALE; MUSCLE FIBRIL; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STREPTOZOCIN DIABETES;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CHRONIC DISEASE; DIABETES MELLITUS, EXPERIMENTAL; ENALAPRIL; GENE EXPRESSION; HEART VENTRICLES; LOSARTAN; MALE; MYOFIBRILS; MYOSIN HEAVY CHAINS; MYOSINS; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER;

ANIMALIA;

EID: 3442890254     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000028765.89855.73     Document Type: Article

References (53)

1. Fein FS, Malhotra A, Miller-Green B, Scheuer J, Sonnenblick EH: Diabetic cardiomyopathy in rats: Mechanical and biochemical response to different insulin doses. Am J Physiol 247: H817-H823, 1984
2. Malhotra A, Lopez MC, Nakouzi A: Troponin subunits contribute to altered myosin ATPase activity in diabetic cardiomyopathy. Mol Cell Biochem 151: 165-172, 1995
3. Fein FS, Strobeck JE, Malhotra A, Scheuer J, Sonnenblick EH: Reversibility of diabetic cardiomyopathy with insulin in rats. Circ Res 49: 1251-1261, 1981
4. Pierce GN, Dhalla NS: Cardiac myofibrillar ATPase activity in diabetic rats. J Mol Cell Cardiol 13: 1063-1069, 1981
5. Takeda N, Dixon IM, Hata T, Elimban V, Shah KR, Dhalla NS: Sequence of alterations in subcellular organelles during the development of heart dysfunction in diabetes. Diabetes Res Clin Pract 30: 113-122, 1996
6. Vadlamudi RV, Rodgers RL, McNeill JH: The effect of chronic alloxan-and streptozotocin-induced diabetes on isolated rat heart performance. Can J Physiol Pharmacol 60: 902-911, 1982
7. Dhalla NS, Pierce GN, Innes IR, Beamish RE: Pathogenesis of cardiac dysfunction in diabetes mellitus. Can J Cardiol 1: 263-281, 1985
8. Dillmann WH: Diabetes mellitus induces changes in cardiac myosin of the rat. Diabetes 29: 579-582, 1980
9. Liu X, Takeda N, Dhalla NS: Troponin I phosphorylation in heart homogenate from diabetic rat. Biochim Biophys Acta 1316: 78-84, 1996
10. Malhotra A, Sanghi V: Regulation of contractile proteins in diabetic heart. Cardiovasc Res 34: 34-40, 1997
11. Pierce GN, Dhalla NS: Mechanisms of the defect in cardiac myofibrillar function during diabetes. Am J Physiol 248: E170-E175, 1985
12. Dhalla NS, Liu X, Panagia V, Takeda N: Subcellular remodelling and heart dysfunction in chronic diabetes. Cardiovasc Res 40: 239-247, 1998
13. Eisenberg E, Greene LE: The relation of muscle biochemistry to muscle physiology. Annu Rev Physiol 42: 293-309, 1980
14. Cassis LA: Downregulation of the renin-angiotensin system in streptozotocin-diabetic rats. Am J Physiol 262: E105-E109, 1992
15. Khatter JC, Sadri P, Zhang M, Hoeschen RJ: Myocardial angiotensin II (Ang II) receptors in diabetic rats. Ann N Y Acad Sci 793: 466-472, 1996
16. Rett K, Jauch KW, Wicklmayr M, Dietze G, Fink E, Mehnert H: Angiotensin-converting enzyme inhibitors in diabetes: Experimental and human experience. Postgrad Med J 62: 59-64, 1986
17. Sechi LA, Griffin CA, Schambelan M: The cardiac renin-angiotensin system in STZ-induced diabetes. Diabetes 43: 1180-1184, 1994
18. Hoenack C, Rosen P: Inhibition of angiotensin type 1 receptor prevents decline of glucose transporter (GLUT4) in diabetic rat heart. Diabetes 45: S82-S87, 1996
19. Rosen P, Rump AF, Rosen R: Influence of angiotensin-converting enzyme inhibition by fosinopril on myocardial perfusion in streptozotocin-diabetic rats. J Cardiovasc Pharmacol 27: 64-70, 1996
20. Rosen R, Rump AF, Rosen P: The ACE-inhibitor captopril improves myocardial perfusion in spontaneously diabetic (BB) rats. Diabetologia 38: 509-517, 1995
21. +-ATPase activity in diabetic rat heart. Am J Physiol 245: C241-C247, 1983
22. Malhotra A, Penpargkul S, Fein FS, Sonnenblick EH, Scheuer J: The effect of streptozotocin-induced diabetes in rats on cardiac contractile proteins. Circ Res 49: 1243-1250, 1981
23. Ganguly PK, Pierce GN, Dhalla KS, Dhalla NS: Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol 244: E528-E535, 1983
24. Penpargkul S, Schaible T, Yipintsoi T, Scheuer J: The effect of diabetes on performance and metabolism of rat hearts. Circ Res 47: 911-921, 1980
25. 2+ binding by and composition of the cardiac sarcolemmal membrane in chronic diabetes. Proc Natl Acad Sci USA 80: 5412-5416, 1983
26. Afzal N, Dhalla NS: Differential changes in left and right ventricular SR calcium transport in congestive heart failure. Am J Physiol 262: H868-H874, 1992
27. Dixon IM, Lee SL, Dhalla NS: Nitrendipine binding in congestive heart failure due to myocardial infarction. Circ Res 66: 782-788, 1990
28. Pfeffer JM, Pfeffer MA, Braunwald E: Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure. Circulation 75: 1149-1155, 1987
29. Dillmann WH: Influence of thyroid hormone administration on myosin ATPase activity and myosin isoenzyme distribution in the heart of diabetic rats. Metabolism 31: 199-204, 1982
30. Effron MB, Bhatnagar GM, Spurgeon HA, Ruano-Arroyo G, Lakatta EG: Changes in myosin isoenzymes, ATPase activity, and contraction duration in rat cardiac muscle with aging can be modulated by thyroxine. Circ Res 60: 238-245, 1987
31. Fiske CH, Subbarow Y: The colorimetric determination of phosphorus. J Biol Chem 66: 375-400, 1925
32. Caforio AL, Grazzini M, Mann JM, Keeling PJ, Bottazzo GF, McKenna WJ, Schiaffino S: Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 85: 1734-1742, 1992
33. Cummins P, Lambert SJ: Myosin transitions in the bovine and human heart. A developmental and anatomical study of heavy and light chain subunits in the atrium and ventricle. Circ Res 58: 846-858, 1986
34. Wang J, Liu X, Ren B, Rupp H, Takeda N, Dhalla NS: Modification of myosin gene expression by imidapril in failing heart due to myocardial infarction. J Mol Cell Cardiol 34: 847-857, 2002
35. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987
36. Tso JY, Sun XH, Kao TH, Reece KS, Wu R: Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13: 2485-2502, 1985
37. Liu X, Takeda N, Dhalla NS: Myosin light-chain phosphorylation in diabetic cardiomyopathy in rats. Metabolism 46: 71-75, 1997
38. 2+-pump ATPase and myosin isoenzymes can be prevented by sucrose. Biochem Biophys Res Commun 164: 319-325, 1989
39. Liu X, Sentex E, Golfman L, Takeda S, Osada M, Dhalla NS: Modification of cardiac subcellular remodelling due to pressure overload by captopril and losartan. Clin Exp Hypertens 21: 145-156, 1999
40. Anthonio RL, van Veldhuisen DJ, van Gilst WH: Left ventricular dilatation after myocardial infarction: ACE inhibitors, beta-blockers, or both? J Cardiovasc Pharmacol 32(suppl 1): S1-S8, 1998
41. Fiordaliso F, Li B, Latini R, Sonnenblick EH, Anversa P, Leri A, Kajstura J: Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II-dependent. Lab Invest 80: 513-527, 2000
42. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T: Oxidative damage to DNA in diabetes mellitus. Lancet 347: 444-445, 1996
43. Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP: Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci USA 96: 10857-10862, 1999
44. Kajstura J, Fiordaliso F, Andreoli AM, Li B, Chimenti S, Medow MS, Limana F, Nadal-Ginard B, Leri A, Anversa P: IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 50: 1414-1424, 2001
45. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-Hope substudy. Lancet 355: 253-259, 2000
46. Berry C, Hamilton CA, Brosnan MJ, Magill FG, Berg GA, McMurray JJ, Dominiczak AF: Investigation into the sources of superoxide in human blood vessels: Angiotensin II increases superoxide production in human internal mammary arteries. Circulation 101: 2206-2212, 2000
47. Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B, Anversa P: Myocardial cell death in human diabetes. Circ Res 87: 1123-1132, 2000
48. Fukai T, Siegfried MR, Ushio-Fukai M, Griendling KK, Harrison DG: Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension. Circ Res 85: 23-28, 1999
49. Leri A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, Malhotra A, Kajstura J, Anversa P: Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest 101: 1326-1342, 1998
50. Liu Y, Leri A, Li B, Wang X, Cheng W, Kajstura J, Anversa P: Angiotensin II stimulation in vitro induces hypertrophy of normal and postinfarcted ventricular myocytes. Circ Res 82: 1145-1159, 1998
51. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG: Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923, 1996
52. von Harsdorf R, Li PF, Dietz R: Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 99: 2934-2941, 1999
53. Zuanetti G, Latini R, Maggioni AP, Franzosi M, Santoro L, Tognoni G: Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: Data from the GISSI-3 study. Circulation 96: 4239-4245, 1997